GO:0003842 L-glutamate gamma-semialdehyde dehydrogenase (NAD+) activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0003842 describes the NAD+-dependent oxidation of L-glutamate 5-semialdehyde to L-glutamate, the final step of proline catabolism.
• The enzyme is often bifunctional, fused to proline dehydrogenase as proline utilization A (PutA) in bacteria or as separate monofunctional enzymes in eukaryotes.
• Structural studies reveal a conserved catalytic mechanism involving a cysteine nucleophile and a hydride transfer to NAD+.
• Mutations in the human enzyme cause type II hyperprolinemia, a metabolic disorder with neurological symptoms.
• The enzyme is a target for inhibitor design against bacterial pathogens and for understanding proline metabolism in cancer.
• CRISPR-based models (knockout, point mutation, knock-in) are essential to dissect its role in disease and metabolism.
Description
L-glutamate gamma-semialdehyde dehydrogenase (NAD+) activity, encoded by GO:0003842, catalyzes the oxidation of L-glutamate 5-semialdehyde to L-glutamate using NAD+ as an electron acceptor. This reaction is the terminal step in proline catabolism, linking proline degradation to the tricarboxylic acid cycle and cellular energy production. The enzyme is widely conserved from bacteria to humans and often exists as a bifunctional polypeptide with proline dehydrogenase, known as proline utilization A (PutA) in bacteria. In eukaryotes, the dehydrogenase domain can be part of a bifunctional enzyme or a separate protein. Researchers study this activity to understand metabolic disorders such as hyperprolinemia, to develop antimicrobials targeting bacterial proline catabolism, and to explore its role in cancer and neurodegeneration. The reaction also produces NADH, which feeds into oxidative phosphorylation, making it a key node in cellular redox balance.
L-glutamate gamma-semialdehyde dehydrogenase (NAD+) activity At A Glance
| GO ID | GO:0003842 |
|---|---|
| GO term | L-glutamate gamma-semialdehyde dehydrogenase (NAD+) activity |
| Ontology | molecular_function |
| Synonym | 1-pyrroline-5-carboxylate dehydrogenase activity; pyrroline-5-carboxylate dehydrogenase activity; delta1-pyrroline-5-carboxylate dehydrogenase activity |
| Major function | Oxidation of L-glutamate 5-semialdehyde to L-glutamate, final step of proline catabolism |
| Cofactor | NAD+ (nicotinamide adenine dinucleotide) |
| Substrate | L-glutamate 5-semialdehyde (spontaneously cyclizes to 1-pyrroline-5-carboxylate) |
| Product | L-glutamate, NADH, and H+ |
| Pathway | Proline degradation (catabolism) |
| EC number | 1.2.1.88 |
What Is GO:0003842?
GO:0003842 is defined as the molecular function that catalyzes the chemical reaction: L-glutamate 5-semialdehyde + NAD+ + H2O = L-glutamate + NADH + 2 H+. In simpler terms, it is an oxidoreductase that converts a semialdehyde into an amino acid, using NAD+ as a cofactor and releasing NADH. This activity is synonymous with 1-pyrroline-5-carboxylate dehydrogenase, as the substrate spontaneously cyclizes to pyrroline-5-carboxylate.
Why Is L-glutamate gamma-semialdehyde dehydrogenase (NAD+) activity Important in Cell Biology?
This activity is critical for proline homeostasis and energy metabolism. Proline is a unique amino acid that can be used as a carbon and nitrogen source, and its catabolism feeds into the TCA cycle. Dysregulation of this enzyme leads to hyperprolinemia, a condition associated with neurological deficits and, in some cases, cancer progression. Moreover, the enzyme is a validated target for antibacterial drug discovery because many pathogens rely on proline catabolism for survival.
• Final step of proline catabolism, linking proline to glutamate and the TCA cycle.
• Mutations cause type II hyperprolinemia, characterized by elevated proline and neurological symptoms.
• Bifunctional enzyme PutA in bacteria is a target for antimicrobial development.
• Involved in redox balance by producing NADH.
• Potential role in cancer metabolism, as proline catabolism supports tumor growth.
• Structural studies guide inhibitor design for both bacterial and human enzymes.
• Used as a model to study bifunctional enzyme mechanisms.
• Relevant to neurodegenerative disorders due to proline accumulation.
• Enables metabolic engineering for proline overproduction.
• Provides insights into enzyme evolution and gene fusion events.
What Happens During L-glutamate gamma-semialdehyde dehydrogenase (NAD+) activity?
Substrate Binding and Cyclization
In simple terms: The substrate spontaneously forms a ring, which fits into the enzyme's active site.
L-glutamate 5-semialdehyde exists in equilibrium with its cyclic form, 1-pyrroline-5-carboxylate (P5C). The enzyme binds P5C, and structural studies show that the active site accommodates the ring, positioning it for catalysis. In bifunctional enzymes like PutA, the dehydrogenase domain is linked to proline dehydrogenase, allowing channeling of P5C from the first active site to the second.
Hydride Transfer to NAD+
In simple terms: The enzyme removes a hydride from the substrate and gives it to NAD+, forming NADH.
The catalytic mechanism involves a conserved cysteine residue that attacks the substrate, forming a thiohemiacetal intermediate. This is followed by hydride transfer to NAD+, reducing it to NADH. The reaction also requires a water molecule, which hydrolyzes the intermediate to release glutamate.
Product Release and Regeneration
In simple terms: Glutamate and NADH are released, and the enzyme is ready for another round.
After catalysis, L-glutamate and NADH diffuse out, and the enzyme returns to its resting state. The NAD+ is regenerated through cellular respiration. In PutA, the dehydrogenase activity is coupled to proline dehydrogenase, ensuring efficient substrate channeling.
Structural Dynamics and Regulation
In simple terms: The enzyme can change shape to control its activity.
Structural analyses of class 3B PutA reveal ligand-induced dimerization and the importance of the C-terminal domain for catalysis. Fragment screening has identified new inhibitor templates that stabilize specific conformations, offering ways to modulate activity.
Key Genes Involved in GO:0003842 L-glutamate gamma-semialdehyde dehydrogenase (NAD+) activity
The following genes encode enzymes with L-glutamate gamma-semialdehyde dehydrogenase (NAD+) activity or are directly involved in its pathway.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ALDH4A1 | Human mitochondrial delta-1-pyrroline-5-carboxylate dehydrogenase | Mutations cause type II hyperprolinemia; studied for structure-function |
| PUTA | Bacterial bifunctional proline dehydrogenase/1-pyrroline-5-carboxylate dehydrogenase | Model for bifunctional enzyme mechanism and drug target |
| P5CS | Bifunctional enzyme catalyzing first two steps of proline biosynthesis | Provides substrate for catabolism; studied in plants and bacteria |
| PRODH | Proline dehydrogenase, first step of proline catabolism | Often fused to ALDH4A1 in bacteria; regulates proline levels |
| ALDH5A1 | Succinic semialdehyde dehydrogenase, related aldehyde dehydrogenase | Mutations cause SSADH deficiency; not directly GO:0003842 but structurally related |
| ALDH2 | Mitochondrial aldehyde dehydrogenase | Similar mechanism but different substrate; used for comparative studies |
| ALDH1B1 | Aldehyde dehydrogenase 1B1 | May have overlapping substrate specificity; studied in cancer |
| GSA1 | Glutamate-1-semialdehyde aminotransferase | Not the same activity but involved in glutamate metabolism |
| P5CR | Pyrroline-5-carboxylate reductase | Reverse reaction in proline biosynthesis; balances catabolism |
| OAT | Ornithine aminotransferase | Produces P5C from ornithine; feeds into GO:0003842 |
| PRODH2 | Proline dehydrogenase 2 | Kidney-specific; may interact with ALDH4A1 |
| SLC25A | Mitochondrial carriers | Transport proline and P5C across membranes |
| GLUD1 | Glutamate dehydrogenase | Links glutamate to TCA cycle; downstream of GO:0003842 |
| GOT1 | Aspartate aminotransferase | Uses glutamate produced by GO:0003842 |
| GOT2 | Mitochondrial aspartate aminotransferase | Metabolizes glutamate in mitochondria |
| IDH2 | Isocitrate dehydrogenase | NADH production linked to GO:0003842 |
| MDH2 | Malate dehydrogenase | TCA cycle enzyme affected by NADH/NAD+ ratio |
How Is L-glutamate gamma-semialdehyde dehydrogenase (NAD+) activity Regulated?
The activity of L-glutamate gamma-semialdehyde dehydrogenase is regulated at multiple levels. In bacteria, PutA is controlled by proline availability and DNA-binding, which switches between transcriptional repressor and enzyme. In humans, ALDH4A1 expression is regulated by metabolic signals and stress, and its activity can be modulated by NAD+ availability. Post-translational modifications and protein-protein interactions may also influence activity, though specific mechanisms require further study.
L-glutamate gamma-semialdehyde dehydrogenase (NAD+) activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ALDH4A1 | Type II hyperprolinemia | Knockout mouse or patient-derived fibroblasts |
| ALDH5A1 | SSADH deficiency | Knockout mouse and iPSC-derived neurons |
| PUTA | Bacterial pathogenesis | Bacterial knockout and inhibitor screening |
| PRODH | Schizophrenia susceptibility | Prodh knockout mouse |
| ALDH4A1 | Cancer metabolism | Cancer cell lines with overexpression/knockdown |
Type II Hyperprolinemia
Mutations in ALDH4A1 cause type II hyperprolinemia, an autosomal recessive disorder characterized by elevated proline levels and neurological manifestations such as seizures and intellectual disability. Structural analysis of mutant enzymes reveals destabilization of the active site, leading to loss of function.
Succinic Semialdehyde Dehydrogenase Deficiency
Although not directly GO:0003842, mutations in ALDH5A1, a related aldehyde dehydrogenase, cause succinic semialdehyde dehydrogenase deficiency, a neurodevelopmental disorder. This highlights the importance of aldehyde dehydrogenases in neurological health.
Cancer Metabolism
Proline catabolism is upregulated in some cancers, where it supports energy production and redox balance. ALDH4A1 expression correlates with tumor progression in certain cancers, making it a potential therapeutic target.
From L-glutamate gamma-semialdehyde dehydrogenase (NAD+) activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of ALDH4A1 cause hyperprolinemia? | ALDH4A1 knockout mouse or cell line |
| What is the catalytic mechanism? | Point mutations in catalytic residues (e.g., Cys) |
| How does PutA channel substrates? | Knock-in of tagged PutA in bacteria |
| Can inhibitors block bacterial PutA? | Overexpression of PutA for screening |
| What is the role of ALDH4A1 in cancer? | Overexpression and knockout in cancer cells |
| How does NAD+ availability affect activity? | Knock-in of NAD+ biosynthetic enzymes |
How to Study the L-glutamate gamma-semialdehyde dehydrogenase (NAD+) activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| NADH absorbance assay | Enzyme activity | Kinetic characterization |
| X-ray crystallography | 3D structure | Active site mapping |
| Site-directed mutagenesis | Functional importance of residues | Mechanistic studies |
| LC-MS metabolomics | Proline, P5C, glutamate levels | Disease models |
| CRISPR knockout | Loss of function | Phenotypic analysis |
| CRISPR knock-in | Tagged or mutant enzyme | Localization and interaction |
| Fragment screening | Inhibitor binding | Drug discovery |
| RNA-seq | Gene expression changes | Pathway regulation |
Enzymatic Assays
Direct measurement of L-glutamate gamma-semialdehyde dehydrogenase activity using NAD+ reduction at 340 nm. This method is used to characterize purified enzymes and mutants.
X-ray Crystallography
Determines three-dimensional structures of the enzyme with substrates or inhibitors, revealing catalytic residues and conformational changes.
Site-Directed Mutagenesis
Introduces point mutations to test the role of specific amino acids in catalysis, as done for ALDH4A1 and PutA.
Metabolomics
Measures proline, P5C, and glutamate levels in cells or tissues to assess pathway flux and enzyme function.
How CRISPR Can Be Used to Study GO:0003842 L-glutamate gamma-semialdehyde dehydrogenase (NAD+) activity
Knockout
CRISPR knockout of ALDH4A1 in cell lines or mice models type II hyperprolinemia, allowing study of proline accumulation and neurological effects.
Point Mutation
Introducing patient-specific mutations (e.g., in ALDH4A1) via CRISPR base editing or HDR recapitulates loss of enzyme activity and helps test therapeutic strategies.
Knock-in
Knock-in of tagged ALDH4A1 or PutA enables live-cell imaging and proteomic analysis of protein interactions and localization.
Overexpression
CRISPR activation or cDNA overexpression of ALDH4A1 increases enzyme levels to study its role in cancer metabolism and redox balance.
How EDITGENE Supports L-glutamate gamma-semialdehyde dehydrogenase (NAD+) activity Research
Researchers studying L-glutamate gamma-semialdehyde dehydrogenase (NAD+) activity-related genes often need to determine whether a candidate gene is causally involved in metabolic pathways, disease progression, or drug response. EDITGENE provides comprehensive CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for L-glutamate gamma-semialdehyde dehydrogenase (NAD+) activity research.
Frequently Asked Questions About L-glutamate gamma-semialdehyde dehydrogenase (NAD+) activity
What is L-glutamate gamma-semialdehyde dehydrogenase (NAD+) activity?
It is an enzymatic activity (GO:0003842) that converts L-glutamate 5-semialdehyde to L-glutamate using NAD+ as a cofactor, the final step of proline catabolism.
What genes are involved in L-glutamate gamma-semialdehyde dehydrogenase (NAD+) activity?
The main human gene is ALDH4A1; in bacteria, the bifunctional putA gene encodes both proline dehydrogenase and this activity.
What diseases are associated with this activity?
Mutations in ALDH4A1 cause type II hyperprolinemia, a metabolic disorder with neurological symptoms.
How is this enzyme regulated?
It is regulated by substrate availability, NAD+ levels, and in bacteria by PutA's dual role as a transcriptional repressor.
What is the reaction catalyzed by GO:0003842?
L-glutamate 5-semialdehyde + NAD+ + H2O = L-glutamate + NADH + 2 H+.
What is the difference between ALDH4A1 and ALDH5A1?
ALDH4A1 catalyzes the final step of proline catabolism (GO:0003842), while ALDH5A1 acts on succinic semialdehyde in GABA metabolism.
How can I study this enzyme activity in the lab?
Use enzymatic assays measuring NADH production, X-ray crystallography, and CRISPR knockout models.
What are the inhibitors of this enzyme?
Fragment screening has identified new inhibitor templates for both proline dehydrogenase and L-glutamate-γ-semialdehyde dehydrogenase.
Is this enzyme a drug target?
Yes, bacterial PutA is a target for antimicrobials, and human ALDH4A1 is explored in cancer metabolism.
What model organisms are used to study GO:0003842?
E. coli PutA, human cell lines, and mouse models are commonly used.
Conclusion
L-glutamate gamma-semialdehyde dehydrogenase (NAD+) activity is a fundamental enzymatic function in proline catabolism, with critical roles in metabolism, disease, and drug discovery. Understanding its mechanism and regulation through CRISPR-based models can reveal new therapeutic opportunities. EDITGENE offers tailored CRISPR services to support this research.
References
- 1. Meeks KR et al.. 2024. Crystallographic Fragment Screening of a Bifunctional Proline Catabolic Enzyme Reveals New Inhibitor Templates for Proline Dehydrogenase and L-Glutamate-γ-semialdehyde Dehydrogenase.. Molecules 29(22) PMID: 39598797
- 2. Campbell AC et al.. 2021. Structural analysis of prolines and hydroxyprolines binding to the l-glutamate-γ-semialdehyde dehydrogenase active site of bifunctional proline utilization A.. Arch Biochem Biophys 698:108727 PMID: 33333077
- 3. Forte-McRobbie CM et al.. 1986. Purification and characterization of human liver "high Km" aldehyde dehydrogenase and its identification as glutamic gamma-semialdehyde dehydrogenase.. J Biol Chem 261(5):2154-63 PMID: 3944130
- 4. Mao Y et al.. 2021. Evidence for Proline Catabolic Enzymes in the Metabolism of Thiazolidine Carboxylates.. Biochemistry 60(47):3610-3620 PMID: 34752700
- 5. Srivastava D et al.. 2012. The three-dimensional structural basis of type II hyperprolinemia.. J Mol Biol 420(3):176-89 PMID: 22516612
- 6. Korasick DA et al.. 2017. Structure and characterization of a class 3B proline utilization A: Ligand-induced dimerization and importance of the C-terminal domain for catalysis.. J Biol Chem 292(23):9652-9665 PMID: 28420730
- 7. Püttmann L et al.. 2013. A novel ALDH5A1 mutation is associated with succinic semialdehyde dehydrogenase deficiency and severe intellectual disability in an Iranian family.. Am J Med Genet A 161A(8):1915-22 PMID: 23825041
- 8. Aral B et al.. 1996. Database cloning human delta 1-pyrroline-5-carboxylate synthetase (P5CS) cDNA: a bifunctional enzyme catalyzing the first 2 steps in proline biosynthesis.. C R Acad Sci III 319(3):171-8 PMID: 8761662
